Error loading player: No playable sources found
4045
Irritable Bowel Syndrome in Inflammatory Bowel Disease: Boundaries Along a Continuum
Date
May 20, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Full DDW 2024 On Demand Program available now!
SOCIETY: AGA IBS-like symptoms in patients with IBD are common, yet presenting a diagnostic and clinical challenge for patients and their providers. This session will review the prevalence of co-existing IBS and IBD, provide practical guidance for identifying and treating IBS-like symptoms in IBD, discuss pathophysiological mechanisms of persistent symptoms in quiescent IBD, and highlight critical knowledge gaps that present future opportunities for research in IBS-IBD overlap.
Moderators
St James's University Hospital
University of California, Los Angeles
Related Products
Gut Microbiome — Ally or Foe for Immune Checkpoint Inhibitors
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…
FDA Town Hall
SOCIETY: AGA The AGA-FDA Town Hall provides health care professionals, clinical trial investigators, and other interested stakeholders an opportunity to hear directly from FDA representatives about the agency's thinking behind recent approvals, safety signals, guidance documents, and boxed warnings…
Irritable Bowel Syndrome Pathophysiology
SOCIETY: AGA
